loading...| Preferred Name |
Dinoprostone |
|
| Synonyms |
|
|
| Definitions |
A synthetic prostaglandin E2 (PGE2) analogue with smooth muscle contraction inducing property. It has been suggested that PGE2 regulates the intracellular levels of cyclic 3, 5-adenosine monophosphate (cAMP) by activating adenylate cyclase and thereby increases cellular membrane calcium ion transport. By acting directly on the myometrium, dinoprostone induces uterine and gastrointestinal smooth muscle contractions. |
|
| ID |
http://purl.obolibrary.org/obo/NCIT_C61727 |
|
| CAS_Registry |
363-24-6 |
|
| CHEBI_ID |
CHEBI:15551 |
|
| Chemical_Formula |
C20H32O5 |
|
| code |
C61727 |
|
| Contributing_Source |
FDA |
|
| definition |
A synthetic prostaglandin E2 (PGE2) analogue with smooth muscle contraction inducing property. It has been suggested that PGE2 regulates the intracellular levels of cyclic 3, 5-adenosine monophosphate (cAMP) by activating adenylate cyclase and thereby increases cellular membrane calcium ion transport. By acting directly on the myometrium, dinoprostone induces uterine and gastrointestinal smooth muscle contractions. |
|
| FDA_UNII_Code |
K7Q1JQR04M |
|
| in_subset | ||
| label |
Dinoprostone |
|
| Legacy Concept Name |
Dinoprostone |
|
| Preferred_Name |
Dinoprostone |
|
| prefixIRI |
NCIT:C61727 |
|
| prefLabel |
Dinoprostone |
|
| Semantic_Type |
Pharmacologic Substance |
|
| UMLS_CUI |
C0012472 |
|
| subClassOf |